Mabion S.A. (WSE:MAB)

Poland flag Poland · Delayed Price · Currency is PLN
9.52
+0.02 (0.21%)
Aug 14, 2025, 11:38 AM CET
-45.16%
Market Cap 153.54M
Revenue (ttm) 37.76M
Net Income (ttm) -39.13M
Shares Out 16.16M
EPS (ttm) -2.42
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,314
Average Volume 18,388
Open 9.51
Previous Close 9.50
Day's Range 9.40 - 9.54
52-Week Range 8.38 - 19.90
Beta 0.44
RSI 41.34
Earnings Date Sep 12, 2025

About Mabion

Mabion S.A., a biopharmaceutical company, provides services as a contract development and manufacturing organization in the process development, analytics, and manufacturing of biologic medicines in Poland. It offers drug substance manufacturing, fill and finish, gene to vial: end-to-end development, process development, analytics, and cell line development and banking services. The company was founded in 2007 and is headquartered in Konstantynów Lódzki, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 213
Stock Exchange Warsaw Stock Exchange
Ticker Symbol MAB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.